caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1568484053

Norman ZuckermanMD

PRACTICEMOUNTAIN STATES ONCOLOGY GROUPSee all providers at this practice →
Medical OncologyBoise, IDI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Norman Zuckerman's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 10 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Daniel Walsh
Pathology · Boise, ID
49276
Dustin Bowman
Physician Assistant · Boise, ID
28406
John Kirkham
Diagnostic Radiology · Boise, ID
1975
Jeffrey Pugsley
Diagnostic Radiology · Boise, ID
1649
Einav Shochat
Diagnostic Radiology · Boise, ID
1647
Dan Zuckerman
Medical Oncology · Boise, ID
1553
Steven Marx
Diagnostic Radiology · Boise, ID
1555
Daniel Ririe
Diagnostic Radiology · Boise, ID
1338
Adam Maxfield
Diagnostic Radiology · Boise, ID
1253
James Hill
Diagnostic Radiology · Boise, ID
1142
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
359
Unique beneficiaries
—
Total services
651
Distinct HCPCS
5
Medicare payment
$45K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 21 Medical Oncology providers in ID — below median (cohort median 924).
PRESCRIBING · PART D · 2024
Total Rx claims
1,225
Beneficiaries
—
Total drug cost
$4.9M
Distinct drugs
27
Brand share
32.6%
Top prescribed drugs
Abiraterone Acetate339 claims
Prednisone227 claims
Ondansetron62 claims
Acalabrutinib Maleate60 claims
Prochlorperazine Maleate48 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.